| Year | 2023 | 2022 |
|---|---|---|
| CF from Operating Activities | 943.6M | 908.2M |
| Net Income | 876.6M | 916.8M |
| Depreciation & Amortization | 170.7M | 155M |
| Deferred Income Taxes | 0 | 0 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | -70.9M | 110.5M |
| Accounts Receivable | -142.3M | -54M |
| Inventory | -59.5M | -120.6M |
| Accounts Payable | 63.3M | 192.6M |
| Other Working Capital | 67.6M | 92.5M |
| Other Non-Cash Items | -32.8M | -274.1M |
| CF from Investing Activities | 943.6M | 908.2M |
| Investments in Property, Plant & Equipment | -692.3M | -327.3M |
| Net Acquisitions | 0 | 800K |
| Investment Purchases | -445.1M | -569.9M |
| Sales/Maturities of Investments | 330.2M | -800K |
| Other Investing Activites | 15.7M | -160.9M |
| CF from Financing Activities | -203.1M | -171.2M |
| Debt Repayment | -100K | -2.8M |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | -198.5M | -158.8M |
| Other Financing Activites | -4.5M | -9.6M |
| Free Cash Flow | 251.3M | 580.9M |
| Operating Cash Flow | 943.6M | 908.2M |
| Capital Expenditures | -692.3M | -327.3M |
| Cash at Beginning of Period | 248.2M | 569.4M |
| Cash at End of Period | 197.2M | 248.2M |
| Net Change In Cash | -51M | -321.2M |
RPG Life Sciences Limited
RPGLIFE.NS
NSE
1969.5INR-69.2 (-3.39%)
RPGLIFE.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 2.51B | 1.99B |
| Net Income | 876.6M | 676.4M |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -198.5M | -158.8M |
| Retained Earnings | 3.18B | 2.51B |
| Other Distributions | 474M | 359.5M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 1.82B | 1.16B |
| Annual Depreciation | 170.7M | 155M |
| Capital Expenditure | -692.3M | -327.3M |
| Net PPE | 2.34B | 1.34B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 0 | 0 |
| Goodwill | 0 | 0 |